tumor biomarkers

Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trial
Varun Monga, Benjamin J Miller, Munir Tanas, Sarag Boukhar, Bryan Allen, Carryn Anderson, Laura Stephens, Stacey Hartwig, Steven Varga, Jon Houtman, Lei Wang, Weizhou Zhang, Omar Jaber, Jon Thomason, David Kuehn, Maheen Rajput, Catherine Metz, K.D. Zamba, Sarah Mott, Chinemerem Abanonu, Sudershan Bhatia, Mohammed Milhem

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e003119; DOI: 10.1136/jitc-2021-003119
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
Jacqueline T Brown, Yuan Liu, Julie M Shabto, Dylan Martini, Deepak Ravindranathan, Emilie Elise Hitron, Greta Anne Russler, Sarah Caulfield, Lauren Yantorni, Shreyas Subhash Joshi, Haydn Kissick, Kenneth Ogan, Bassel Nazha, Bradley C Carthon, Omer Kucuk, Wayne B Harris, Viraj A Master, Mehmet Asim Bilen

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002851; DOI: 10.1136/jitc-2021-002851
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study
Sandra P D'Angelo, Celeste Lebbé, Laurent Mortier, Andrew S Brohl, Nicola Fazio, Jean-Jacques Grob, Natalie Prinzi, Glenn J Hanna, Jessica C Hassel, Felix Kiecker, Sara Georges, Barbara Ellers-Lenz, Parantu Shah, Gülseren Güzel, Paul Nghiem

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002646; DOI: 10.1136/jitc-2021-002646
Predictive value of 3′-deoxy-3′-¹⁸F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
Masayuki Sato, Yukihiro Umeda, Tetsuya Tsujikawa, Tetsuya Mori, Miwa Morikawa, Masaki Anzai, Yuko Waseda, Maiko Kadowaki, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e003079; DOI: 10.1136/jitc-2021-003079
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
Shujing Wang, Hua Zhu, Yingjie Li, Jin Ding, Feng Wang, Lixin Ding, Xinyu Wang, Jun Zhao, Yan Zhang, Yunfeng Yao, Tong Zhou, Nan Li, Aiwen Wu, Zhi Yang

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002926; DOI: 10.1136/jitc-2021-002926
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Katharina Filipski, Michael Scherer, Kim N. Zeiner, Andreas Bucher, Johannes Kleemann, Philipp Jurmeister, Tabea I. Hartung, Markus Meissner, Karl H. Plate, Tim R. Fenton, Jörn Walter, Sascha Tierling, Bastian Schilling, Pia S. Zeiner, Patrick N. Harter

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002226; DOI: 10.1136/jitc-2020-002226
Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer
Miok Kim, Yong Ki Min, Jinho Jang, Hyejin Park, Semin Lee, Chang Hoon Lee

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002503; DOI: 10.1136/jitc-2021-002503
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
Kerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, William C Louv, Teilo H Schaller, Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B Johnson, Osama Rahma, Elad Sharon

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002896; DOI: 10.1136/jitc-2021-002896
Author response to Colle et al
Giovanni Fucà, Francesca Corti, Filippo Pietrantonio

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e003138; DOI: 10.1136/jitc-2021-003138
Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy
Lin Xie, Kuan Hu, Yanhong Duo, Takashi Shimokawa, Katsushi Kumata, Yiding Zhang, Cuiping Jiang, Lulu Zhang, Nobuki Nengaki, Hidekatsu Wakizaka, Yihai Cao, Ming-Rong Zhang

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002616; DOI: 10.1136/jitc-2021-002616

Main menu

tumor biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

tumor biomarkers

Pages